• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

迈向消除间日疟原虫疟疾：实施根治措施。

Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure.

机构信息

Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia.

Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

出版信息

PLoS Med. 2021 Apr 23;18(4):e1003494. doi: 10.1371/journal.pmed.1003494. eCollection 2021 Apr.

DOI:10.1371/journal.pmed.1003494
PMID:33891589
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8064598/
Abstract

In this review for the Vivax malaria collection, Kamala Thriemer and colleagues explore efforts to eliminate P. vivax malaria.

摘要

在这篇关于间日疟原虫收藏的综述中，Kamala Thriemer 及其同事探讨了消除间日疟原虫疟疾的努力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4c/8064598/992e4dccec3f/pmed.1003494.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4c/8064598/9ba5a68d1382/pmed.1003494.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4c/8064598/992e4dccec3f/pmed.1003494.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4c/8064598/9ba5a68d1382/pmed.1003494.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4c/8064598/992e4dccec3f/pmed.1003494.g002.jpg

相似文献

1
Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure.迈向消除间日疟原虫疟疾：实施根治措施。
PLoS Med. 2021 Apr 23;18(4):e1003494. doi: 10.1371/journal.pmed.1003494. eCollection 2021 Apr.
2
Investigation of P. vivax elimination via mass drug administration: A simulation study.经大规模药物治疗消除间日疟的研究：一项模拟研究。
Epidemics. 2024 Sep;48:100789. doi: 10.1016/j.epidem.2024.100789. Epub 2024 Aug 31.
3
[Role of primaquine in malaria control and elimination in French-speaking Africa].[伯氨喹在非洲法语区疟疾控制与消除中的作用]
Bull Soc Pathol Exot. 2017 Aug;110(3):198-206. doi: 10.1007/s13149-017-0556-z. Epub 2017 Apr 17.
4
Is zoonotic Plasmodium vivax malaria an obstacle for disease elimination?人兽共患的间日疟原虫疟疾是否是消除疾病的障碍？
Malar J. 2022 Nov 17;21(1):343. doi: 10.1186/s12936-022-04349-6.
5
Missed Plasmodium falciparum and Plasmodium vivax Mixed Infections in Ethiopia Threaten Malaria Elimination.在埃塞俄比亚，疟原虫混合感染（恶性疟原虫和间日疟原虫）的漏检，威胁着疟疾消除工作。
Am J Trop Med Hyg. 2021 Nov 30;106(2):667-670. doi: 10.4269/ajtmh.21-0796.
6
Radical cure for Plasmodium vivax malaria after G6PD qualitative testing in four provinces in Cambodia, results from Phase I implementation.柬埔寨四个省进行 G6PD 定性检测后对间日疟原虫的根治，第一阶段实施结果。
Malar J. 2024 Feb 23;23(1):56. doi: 10.1186/s12936-024-04884-4.
7
Malaria Trigram: improving the visualization of recurrence data for malaria elimination.疟疾三因图：改进疟疾消除中复发数据的可视化效果。
Malar J. 2021 Oct 30;20(1):431. doi: 10.1186/s12936-021-03964-z.
8
Plasmodium vivax: a roadblock on the quest to eliminate malaria.间日疟原虫：消除疟疾征程上的一个障碍。
Lancet Infect Dis. 2015 Oct;15(10):1127-1128. doi: 10.1016/S1473-3099(15)00237-6. Epub 2015 Jul 25.
9
Dynamics of Plasmodium vivax populations in border areas of the Greater Mekong sub-region during malaria elimination.消除疟疾期间大湄公河次区域边境地区间日疟原虫种群动态。
Malar J. 2020 Apr 8;19(1):145. doi: 10.1186/s12936-020-03221-9.
10
Control and elimination of Plasmodium vivax.控制和消除间日疟原虫。
Adv Parasitol. 2012;80:301-41. doi: 10.1016/B978-0-12-397900-1.00006-2.

引用本文的文献

1
Efficacy of Focal Primaquine Mass Administration for Eliminating Malaria in Northern Myanmar: A Cluster-Randomized Trial.在缅甸北部进行的群体随机试验：采用伯氨喹局部群体给药法消除疟疾的疗效
Open Forum Infect Dis. 2025 Aug 5;12(8):ofaf465. doi: 10.1093/ofid/ofaf465. eCollection 2025 Aug.
2
Potent Acridone Antimalarial against All Three Life Stages of .对疟原虫所有三个生命周期阶段均有效的强力吖啶酮抗疟药 。（你提供的原文似乎不完整，这里根据常见的语境补充了“疟原虫”，以使译文更通顺合理）
Res Sq. 2025 Jun 27:rs.3.rs-6858328. doi: 10.21203/rs.3.rs-6858328/v1.
3
High daily dose Short COurse PrimaquinE after G6PD testing for the radical cure of Plasmodium vivax malaria in Indonesia and Papua New Guinea: the SCOPE implementation study protocol.

本文引用的文献

1
Malaria Elimination in Costa Rica: Changes in Treatment and Mass Drug Administration.哥斯达黎加的疟疾消除：治疗与大规模药物管理的变化
Microorganisms. 2020 Jun 30;8(7):984. doi: 10.3390/microorganisms8070984.
2
Primaquine for Plasmodium vivax malaria treatment.用于间日疟原虫疟疾治疗的伯氨喹。
Lancet. 2020 Jun 27;395(10242):1971-1972. doi: 10.1016/S0140-6736(20)30242-7.
3
Estimating the Proportion of Recurrences Caused by Relapse: A Systematic Review and Meta-Analysis.估算复发引起的复发比例：系统评价和荟萃分析。
印度尼西亚和巴布亚新几内亚采用高剂量短疗程伯氨喹啉并在葡萄糖-6-磷酸脱氢酶（G6PD）检测后用于间日疟原虫疟疾根治的研究：SCOPE实施研究方案
BMC Infect Dis. 2025 Jul 16;25(1):922. doi: 10.1186/s12879-025-11109-9.
4
Piloting the options assessment toolkit with national malaria programme leaders from the Asia-Pacific countries: a meeting report.与亚太国家国家疟疾规划负责人共同试用选项评估工具包：会议报告
Malar J. 2025 Jun 12;24(1):187. doi: 10.1186/s12936-025-05432-4.
5
Co-design of a routine clinical review to improve the safety of high dose radical cure treatment for Plasmodium vivax malaria: findings from Cambodia and Ethiopia.共同设计常规临床评估以提高间日疟原虫疟疾高剂量根治治疗的安全性：来自柬埔寨和埃塞俄比亚的研究结果
Malar J. 2025 May 28;24(1):171. doi: 10.1186/s12936-025-05425-3.
6
Enhancing Primaquine Adherence for Plasmodium vivax Malaria: A Cluster-Randomized Controlled Trial in Myanmar.提高间日疟原虫疟疾的伯氨喹依从性：缅甸的一项整群随机对照试验。
Am J Trop Med Hyg. 2025 May 6;113(1):57-66. doi: 10.4269/ajtmh.24-0814. Print 2025 Jul 2.
7
FocaL mass drug Administration for Plasmodium vivax Malaria Elimination (FLAME): study protocol for an open-label cluster randomized controlled trial in Peru.用于间日疟消除的局部群体药物管理（FLAME）：秘鲁一项开放标签整群随机对照试验的研究方案
Res Sq. 2025 Apr 17:rs.3.rs-5594891. doi: 10.21203/rs.3.rs-5594891/v1.
8
Evaluation of the transmission-blocking potential of antigen Pvg37 using transgenic rodent parasites and clinical isolates.利用转基因啮齿动物寄生虫和临床分离株评估抗原Pvg37的传播阻断潜力。
Front Cell Infect Microbiol. 2025 Jan 24;15:1529770. doi: 10.3389/fcimb.2025.1529770. eCollection 2025.
9
Quantifying Plasmodium vivax radical cure efficacy: a modelling study integrating clinical trial data and transmission dynamics.间日疟原虫根治疗效的量化：一项整合临床试验数据与传播动力学的建模研究
Lancet Infect Dis. 2025 Jun;25(6):668-677. doi: 10.1016/S1473-3099(24)00689-3. Epub 2025 Jan 13.
10
Profiling vivax malaria incidence, residual transmission, and risk factors using reactive case detection in low transmission settings of Ethiopia.利用反应性病例检测在埃塞俄比亚低传播环境中分析间日疟发病率、残余传播和危险因素。
Malar J. 2024 Nov 29;23(1):362. doi: 10.1186/s12936-024-05171-y.
Am J Trop Med Hyg. 2020 Sep;103(3):1094-1099. doi: 10.4269/ajtmh.20-0186.
4
Plasmodium vivax in the Era of the Shrinking P. falciparum Map.《在恶性疟原虫地图不断缩小的时代中的间日疟原虫》
Trends Parasitol. 2020 Jun;36(6):560-570. doi: 10.1016/j.pt.2020.03.009. Epub 2020 Apr 22.
5
Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis.分光光度法检测葡萄糖-6-磷酸脱氢酶活性的定量研究：系统评价和荟萃分析。
PLoS Med. 2020 May 14;17(5):e1003084. doi: 10.1371/journal.pmed.1003084. eCollection 2020 May.
6
Health policy impacts on malaria transmission in Costa Rica.哥斯达黎加的卫生政策对疟疾传播的影响。
Parasitology. 2020 Aug;147(9):999-1007. doi: 10.1017/S0031182020000621. Epub 2020 Apr 28.
7
Tools to accelerate falciparum malaria elimination in Cambodia: a meeting report.加速柬埔寨消除恶性疟的工具：会议报告。
Malar J. 2020 Apr 15;19(1):151. doi: 10.1186/s12936-020-03197-6.
8
Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials.大剂量使用双氢青蒿素哌喹和单剂低剂量伯氨喹来消除恶性疟原虫对间日疟原虫仅有短暂影响：随机对照试验的结果。
PLoS One. 2020 Feb 5;15(2):e0228190. doi: 10.1371/journal.pone.0228190. eCollection 2020.
9
Evaluation of the CareStart™ glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in the field settings and assessment of perceived risk from primaquine at the community level in Cambodia.在柬埔寨的现场环境中评估 CareStart™葡萄糖-6-磷酸脱氢酶（G6PD）快速诊断检测，以及在社区层面评估来自 Primaquine 的感知风险。
PLoS One. 2020 Jan 31;15(1):e0228207. doi: 10.1371/journal.pone.0228207. eCollection 2020.
10
Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study.伊维菌素作为一种新颖的疟疾控制辅助工具，可降低发病率和患病率：建模研究。
Lancet Infect Dis. 2020 Apr;20(4):498-508. doi: 10.1016/S1473-3099(19)30633-4. Epub 2020 Jan 13.